Concomitant Use of Gardasil (V501) (Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) With Combined Diphtheria, Tetanus, Pertussis Vaccine and Meningococcal Conjugate Vaccine in Adolescents - Related Studies - ClinicalTrials.gov

Skip to Main Content

ClinicalTrials.gov

Home Search Study Topics Glossary


	Full Text View


	Tabular View


	Study Results


	Related Studies

Concomitant Use of Gardasil (V501) (Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) With Combined Diphtheria, Tetanus, Pertussis Vaccine and Meningococcal Conjugate Vaccine in Adolescents

This study has been completed.

Study NCT00325130 Information provided by Merck

First Received: May 11, 2006 Last Updated: October 1, 2009 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Neoplasms, Glandular and Epithelial
Diphtheria
Tetanus
Whooping Cough
Meningitis

Additional conditions recognized in this trial

Neoplasms

More general conditions related to this trial

Actinomycetales Infections
Bacterial Infections
Bordetella Infections
Central Nervous System Diseases
Central Nervous System Infections
Clostridium Infections
Corynebacterium Infections
Gram-Negative Bacterial Infections
Gram-Positive Bacterial Infections
Infection
Neoplasms by Histologic Type
Nervous System Diseases
Respiratory Tract Diseases
Respiratory Tract Infections

Interventions listed in this trial

Comparator: Menactra™ (Concomitant)
Comparator: Adacel™ (Concomitant)
Comparator: Adacel™

Sponsors listed in this trial

Merck

Back to top of Main Content